We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Virotec Intl | LSE:VTI | London | Ordinary Share | GB00B15PVR02 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.50 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 1746W Virotec International PLC 06 June 2008 Virotec International plc 6 June 2008 This announcement does not constitute an offer to purchase or a solicitation of an offer to sell any securities. Not for release, publication or distribution, in whole or in part in, into or from the United States of America or any of its territories, Canada, or Japan, or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. Virotec International plc ("Virotec" or the "Company") Court Meeting and General Meeting Results Virotec International plc (AIM: VTI) today announces that at the meeting convened by direction of the High Court of England and Wales (the "Court") and held earlier today, 6 June 2008, (the "Court Meeting") the proposed scheme of arrangement (the "Scheme") between the Company and the holders of Scheme Shares (as defined in the circular to Virotec shareholders dated 13 May 2008 (the "Scheme Document")) to implement the acquisition of the Company by Hydrodec Group plc (the "Acquisition") was approved by the requisite majority on a poll. At the General Meeting of Virotec shareholders, held subsequent to the Court Meeting, the special resolution for the purpose of giving effect to the Scheme, and the ordinary resolution approving the Disposal (as defined in the Scheme Document) were also approved by the requisite majorities by a vote on a show of hands. Completion of the Acquisition is subject to the satisfaction or, if permitted, waiver of the remaining conditions of the Acquisition and the sanction of the Scheme by the Court. It is expected that the Court sanction will be received at the Court hearing listed for 23 June 2008. Enquiries: Virotec International plc Angus Craig Tel: + 61 7 5573 3353 Arden Partners plc Christopher Hardie / Matthew Armitt Tel: +44 (0)20 7398 1600 Arden Partners plc, which is regulated in the United Kingdom by the Financial Services Authority, is acting for Virotec and no-one else in connection with the Acquisition and Disposal (as defined in the Scheme Document) and will not be responsible to anyone other than Virotec for providing the protections afforded to customers of Arden or for providing advice in relation to the Acquisition and Disposal or any other matter referred to in this announcement. This information is provided by RNS The company news service from the London Stock Exchange END ROMUUURWQUPRGGQ
1 Year Virotec Chart |
1 Month Virotec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions